T1	Participants 546 596	665 patients with a history of colorectal adenomas
T2	Participants 756 768	Participants
T3	Participants 904 915	23 patients
T4	Participants 922 924	15
T5	Participants 949 951	45
T6	Participants 984 988	five
T7	Participants 1050 1066	552 participants
T8	Participants 1108 1110	94
T9	Participants 1170 1172	28
T10	Participants 1219 1236	58 (29.3%) of 198
T11	Participants 1173 1196	(15.9%) of 176 patients
T12	Participants 1261 1300	36 (20.2%) of 178 in the placebo group.
T13	Participants 1803 1811	patients
